Advantages and disadvantages of hormone injections for birth control

Content provided by Healthwise

Advantages and disadvantages of hormone injections for birth control

The following table lists the advantages and disadvantages of using the Depo-Provera injection birth control method.

**Depo-Provera (progestin-only injection)**
Advantages	Disadvantages
Injections are needed only every 12 weeks Reduces risk for endometrial and ovarian cancer Reduces symptoms of endometriosis Reduces risk of pelvic inflammatory disease (PID) Reduces risk of ectopic pregnancy Reduces frequency of seizures in women who have a seizure disorder Reduces number of sickle cell crises in women who have sickle cell disease Can be used after a miscarriage or an abortion Reduces cramps and pain at ovulation	Using Depo-Provera for 2 or more years can cause bone loss, which may not be fully reversible after stopping the medication. Bone thinning can lead to osteoporosis in later life. This concern may be greatest during the teen years, when young women should be building bone mass.¹ Talk to your health professional about whether the benefits of long-term use outweigh your risks and how you can protect your bones with daily calcium and regular weight-bearing exercise, such as walking or running.² Often causes irregular spotting Causes slight weight gain Fertility may not return for 6 to 8 months after stopping the medication May decrease levels of HDL ("good") cholesterol Provides no protection against sexually transmitted diseases (STDs) May increase the risk of chlamydia or gonorrhea infection among women who are sexually exposed to these bacteria. (Depo-Provera users who have any risk of exposure to STDs are advised to use condoms.³)

References

Citations
U.S. Food and Drug Administration (2004). Black box warning added concerning long-term use of Depo-Provera contraceptive injection. FDA Talk Paper No. T04-50. Available online: http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html.
Hatcher RA (2004). Depo-Provera injections, implants, and progestin-only pills (minipills). In RA Hatcher et al., eds., Contraceptive Technology, 18th ed., pp. 461–494. New York: Ardent Media.
Morrison CS, et al. (2004). Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sexually Transmitted Diseases, 31(9): 561–567.

Credits

Author	Merrill Hayden
Editor	Kathleen M. Ariss, MS
Associate Editor	Terrina Vail
Primary Medical Reviewer	Joy Melnikow, MD, MPH - Family Medicine
Specialist Medical Reviewer	Kirtly Jones, MD - Obstetrics and Gynecology
Last Updated	May 23, 2006

Last updated:	May 23, 2006
Author:	Merrill Hayden
Reviewed By:	Joy Melnikow, MD, MPH - Family Medicine, Kirtly Jones, MD - Obstetrics and Gynecology
Editors:	Kathleen M. Ariss, MS, Terrina Vail

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.